GlassScriptPhysician profile
Slobodan Miric
NPI 1710908934
$36,533.35
in general payments reported to CMS, 2019-2025
54 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,218 · 2020: $13K · 2021: $6,429 · 2022: $9,727 · 2023: $1,229 · 2024: $2,101 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,806 · Education: $0.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,806.48 |
| Education | $0.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12,927.21 | 2020-2022 | |
| Abbvie INC. | $7,388.26 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $7,250.22 | 2022 | |
| Emd Serono, INC. | $1,435.85 | 2019-2024 | Mavenclad |
| Supernus Pharmaceuticals, INC. | $1,203.37 | 2019-2025 | Qelbree, Qelbree |
| Teva Pharmaceuticals USA, INC. | $661.17 | 2019-2025 | Austedo Xr, Austedo Xr |
| Pfizer INC. | $650.47 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $642.53 | 2019-2025 | |
| Lilly USA, LLC | $549.53 | 2019-2024 | Kisunla, Amyvid, Reyvow |
| Sk Life Science, INC. | $364.32 | 2020-2025 | Xcopri |
| Amgen INC. | $338.97 | 2019-2023 | Aimovig |
| Argenx US, INC. | $337.73 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| E.R. Squibb & Sons, L.L.C. | $321.45 | 2020-2024 | Zeposia |
| Csl Behring | $283.11 | 2019-2025 | Hizentra |
| Biogen, INC. | $231.47 | 2019-2023 | Tysabri, Vumerity |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Slobodan Miric listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.